Category Archives: Pharma & Biotech

Pharma & Biotech Press Releases & News distributed via EuropaWire

European Society of Cardiology to hold annual EuroCMR congress on 6 to 8 May online

(PRESS RELEASE) SOPHIA ANTIPOLIS CEDEX, France, 12-Apr-2021 — /EuropaWire/ — EuroCMR 2021 will highlight how magnetic resonance imaging (MRI) of the heart helps physicians pinpoint diagnoses and tailor treatment. EuroCMR 2021 will take place on 6 to 8 May online. … Read the full press release

Sanofi launches more impactful Corporate Social Responsibility (CSR) strategy

Accelerating projects on access to medicines, support for vulnerable communities, environmental conservation, and diversity and inclusion Creation of Sanofi Global Health, global nonprofit unit to provide 40 of the world’s poorest countries access to 30 essential medicines (PRESS RELEASE) PARIS, 7-Apr-2021 — … Read the full press release

Largest Supply Chain for Face masks, FFP2, FFP3 and cloth masks

Creative Concepts Manufacturing Group Unveils its innovative 5-Layer Nano-PTFE Filtering Technology Reusable and Washable Cloth Mask for everyday civilians – AirGuard™ Face Mask (PRESS RELEASE) BOLOGNA, 31-Mar-2021 — /EuropaWire/ — Creative Concepts Manufacturing Group announces campaign launch of their new … Read the full press release

Novartis welcomes new Chief Legal Officer Karen L. Hale

(PRESS RELEASE) BASEL, 22-Mar-2021 — /EuropaWire/ — Swiss multinational pharmaceutical Novartis appoints Karen L. Hale as Chief Legal Officer. She succeeds Shannon Klinger. Karen will be based in Basel, Switzerland and will join the Executive Committee of Novartis (ECN) and … Read the full press release

Covestro’s new polycarbonates supports the advancement of drug delivery devices and surgical instruments

(PRESS RELEASE) LEVERKUSEN, 16-Mar-2021 — /EuropaWire/ — Covestro announces new polycarbonates for development of drug delivery devices and surgical instruments. Covestro offers two new families of the polycarbonate Makrolon®: improved low-friction types and maximum strength glass-filled products. The latter are also … Read the full press release

FB Vision and Bausch+Lomb enter into multi-country commercial agreement to commercialize Ozodrop™ Eye Drops

(PRESS RELEASE) SAN BENEDETTO DEL TRONTO, Italy, 15-Mar-2021 — /EuropaWire/ — FB Vision, an Italian joint stock company specialized in ophthalmics, announced a partnership with Bausch + Lomb, a leading global eye health business of Bausch Health Companies Inc., to … Read the full press release

Thomas Leysen appointed Chairman of DSM Supervisory Board

(PRESS RELEASE) HEERLEN, 4-Mar-2021 — /EuropaWire/ — Royal DSM, a global science-based company in Nutrition, Health and Sustainable Living, announces the retirement of Rob Routs as Chairman and member of the DSM Supervisory Board at the close of the Annual … Read the full press release

Kuehne+Nagel strengthens its presence in pharma and healthcare logistics in China through partnership with Jointown

Extensive cooperation across warehousing, domestic distribution, international transports and logistics In support of Chinese pharma customers’ access to international markets, leveraging Kuehne+Nagel’s global pharma network (PRESS RELEASE) SHANGHAI, China, 24-Feb-2021 — /EuropaWire/ — Global transport and logistics leader Kuehne+Nagel announces … Read the full press release

A URSAPHARM Arzneimittel e a CEBINA anunciam uma parceria com vista a reaproveitar o anti-histamínico azelastina para combater a COVID-19

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

(PRESS RELEASE) SAARBRÜCKEN / VIENA, 17-Feb-2021 — /EuropaWire/ — Na luta contra o vírus SARS-CoV-2, um grande número de empresas farmacêuticas está em busca de novas abordagens para combater a pandemia. Além das vacinas, estão a ser feitos esforços intensivos … Read the full press release

URSAPHARM Arzneimittel et CEBINA annoncent un partenariat pour reconvertir l’antihistaminique azélastine afin de lutter contre la COVID-19

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

(PRESS RELEASE) SARREBRUCK / VIENNE, 17-Feb-2021 — /EuropaWire/ — Dans la lutte contre le virus SRAS-CoV-2, un grand nombre d’entreprises pharmaceutiques recherchent de nouvelles approches pour combattre la pandémie. Outre les vaccins, des efforts intensifs de recherche et développement à … Read the full press release

URSAPHARM Arzneimittel y CEBINA anuncian una colaboración para readaptar el antihistamínico azelastine para combatir la COVID-19

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

(PRESS RELEASE) SAARBRÜCKEN / VIENA, 17-Feb-2021 — /EuropaWire/ — En la lucha contra el virus SARS-CoV-2, una gran cantidad de empresas farmacéuticas están buscando nuevos enfoques para combatir la pandemia. Además de las vacunas, las iniciativas exhaustivas de investigación y … Read the full press release

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

URSAPHARM Arzneimittel and CEBINA announce partnership to repurpose the antihistamine azelastine to combat COVID-19

(PRESS RELEASE) SAARBRÜCKEN / VIENNA, 17-Feb-2021 — /EuropaWire/ — In the fight against the SARS-CoV-2 virus, a large number of pharmaceutical companies are looking for new approaches to combat the pandemic. In addition to vaccines, intensive research and development efforts … Read the full press release

DHL Global Forwarding plays important role in COVID-19 vaccine distribution in Japan

DHL Global Forwarding contracted for vaccine distribution to Japan First successful delivery to Japan completed end of last week Pharma freezers at DHL facility in Japan ensure vaccine is stored at -70 degrees until final delivery (PRESS RELEASE) BONN, 15-Feb-2021 … Read the full press release

Lundbeck commits to become carbon neutral across the entire value chain by 2050

(PRESS RELEASE) COPENHAGEN, 4-Feb-2021 — /EuropaWire/ — Danish international pharmaceutical company H. Lundbeck A/S (Lundbeck) announces its new 15-year climate target, which includes a detailed action plan to reduce emissions, approved by the Science Based Targets initiative (SBTi), towards becoming … Read the full press release

COVID-19 Vaccine AstraZeneca confirmed safe and effective at preventing COVID-19

Increased efficacy with longer inter-dose interval Protection of over 70% starting after a first dose First indication of reduction in disease transmission of up to 67% (PRESS RELEASE) CAMBRIDGE, 3-Feb-2021 — /EuropaWire/ — AstraZeneca (LSE/STO/Nasdaq: AZN), a British–Swedish multinational pharmaceutical … Read the full press release

Genetic diversity: GSK and Novartis launch Project Africa GRADIENT to optimise treatment responses for malaria and tuberculosis in Africa

Project Africa GRADIENT calls on local researchers to submit proposals exploring the link between genetic diversity and response to malaria and tuberculosis drugs in African patients. Combined funding commitment of GBP 2.8 million (USD 3.6 million) over five years. Researchers … Read the full press release

Sanofi gains full global rights to a promising antibody for inflammatory disorders with the acquisition of Kymab

(PRESS RELEASE) PARIS/ CAMBRIDGE, 11-Jan-2021 — /EuropaWire/ — French multinational pharmaceutical company Sanofi to acquire Kymab, a clinical-stage biopharmaceutical company developing fully human monoclonal antibodies with a focus on immune-mediated diseases and immuno-oncology therapeutics. The agreement includes an upfront payment … Read the full press release

QIAGEN appoints Dr. Toralf Haag as a member of the Supervisory Board and the Audit Committee

(PRESS RELEASE) VENLO, the Netherlands, 8-Jan-2021 — /EuropaWire/ — QIAGEN announces the appointment of Dr. Toralf Haag as a member of the Supervisory Board with immediate effect. He will also become a member of the Audit Committee. Dr. Haag was … Read the full press release

Kuehne+Nagel takes responsibility of global distribution of Covid-19 Vaccine Moderna

New arrangement leverages Kuehne+Nagel’s global solutions for pharma & healthcare logistics (PRESS RELEASE) CAMBRIDGE, MA, U.S.A. / SCHINDELLEGI, 7-Jan-2021 — /EuropaWire/ — Global transport and logistics company Kuehne+Nagel announces international supply chain arrangement with Moderna, Inc. (NASDAQ:MRNA), a biotechnology company … Read the full press release

Lundbeck welcomes acceptance of Vyepti’s marketing authorization application by the European Medicines Agency for the prevention of migraine

(PRESS RELEASE) VALBY, Denmark, 22-Dec-2020 — /EuropaWire/ — Danish international pharmaceutical company, H. Lundbeck A/S (Lundbeck) announces that its marketing authorization application for Vyepti™ (eptinezumab-jjmr) has been accepted by the European Medicines Agency (EMA). The filing seeks approval to introduce … Read the full press release

Aimmune Therapeutics’ PALFORZIA the first-ever treatment option approved for peanut allergy in the EU

(PRESS RELEASE) VEVEY, 21-Dec-2020 — /EuropaWire/ — Nestlé Health Science Company, Aimmune Therapeutics announces that PALFORZIA® [defatted powder of Arachis hypogaea L., semen (peanuts)], has been approved by the European Commission for the treatment of peanut allergy in the European … Read the full press release

OHMX.bio and Fujirebio Europe to develop clinical in vitro diagnostics platform incorporating third generation sequencing technologies

IVD-seq project received 720K EURO research grant from Flanders Innovation & Entrepreneurship (VLAIO) (PRESS RELEASE) GENT, 8-Dec-2020 — /EuropaWire/ — Fujirebio Europe announces that together with its partner OHMX.bio, a provider of cutting-edge “omics” solutions, have been awarded a 720K … Read the full press release

EIB signs €15.0 million financing deal with AB Science to support the development of masitinib as a treatment for COVID-19

Financing deal worth €15.0 million signed to support clinical development programme for masitinib Masitinib developed as a credible candidate for treating COVID-19 in addition to other diseases for which no therapeutic solutions are available (PRESS RELEASE) PARIS, 30-Nov-2020 — /EuropaWire/ — … Read the full press release

Novozymes welcomes new Executive Vice President of People, Sustainability & Brand Morten Enggaard Rasmussen

(PRESS RELEASE) COPENHAGEN, 26-Nov-2020 — /EuropaWire/ — Global biotechnology company Novozymes announces the appointment of Morten Enggaard Rasmussen as Executive Vice President of People, Sustainability & Brand succeeding Thomas Videbæk. Morten will take up his new position on 1 April, … Read the full press release

Almirall’s open innovation platform AlmirallShare announces two new partnerships aimed at finding new ways for the treatment of skin cancer and atopic dermatitis

These collaborations are in response to the calls for innovation via AlmirallShare, the open innovation platform of Almirall and aim to identify new biosignatures and treatments for skin cancer and atopic dermatitis AlmirallShare is responsible for 50% of the private-public … Read the full press release

AstraZeneca’s Imfinzi (durvalumab) approved in the US for new four-week 1,500mg fixed-dosing option

(PRESS RELEASE) CAMBRIDGE, 20-Nov-2020 — /EuropaWire/ — AstraZeneca (LON: AZN), a global, science-led biopharmaceutical company, has announced the US Food and Drug Administration (FDA) approval of its Imfinzi (durvalumab) for an additional dosing option, a 1,500mg fixed dose every four … Read the full press release

Novartis signs 10 year 78 MW renewable Virtual Power Purchase Agreement (VPPA) with Enel Green Power

The energy will be generated by the 179.9 MW TICO Wind Farm, located in the Spanish province of Zaragoza, Enel Green Power will be a “Green Enabler” for Novartis, supporting the company along its environmental sustainability journey (PRESS RELEASE) ROME, … Read the full press release

Henkel closes epiCS® Skin Model Technology acquisition from SkinInVitro GmbH

Attractive portfolio with strong and successful models of the human skin Global dissemination of regulatory approved alternative test methods Important step towards the worldwide use and distribution of alternative test methods (PRESS RELEASE) DÜSSELDORF, 3-Nov-2020 — /EuropaWire/ — Henkel (ETR: … Read the full press release

Zeta Group and Siemens to work together for digital transformation of pharmaceutical processes

Strategic partnership for digital transformation of pharmaceutical processes Operational usage of digital plant data New Smart Engineering Services (SES) New modules improve integration in the value chain (PRESS RELEASE) NUREMBERG/ LIEBOCH/ GRAZ, 3-Nov-2020 — /EuropaWire/ — Siemens and Zeta Gmbh … Read the full press release

Palette Life Sciences expands availability of online education and resources for paediatric urologists across Europe

Palette Life Sciences provides valuable information regarding vesicoureteral reflux (VUR) to paediatric urologists in France, Germany, Italy and Spain (PRESS RELEASE) SANTA BARBARA, CALIF. / STOCKHOLM, 27-Oct-2020 — /EuropaWire/ — Palette Life Sciences, a fully integrated global life sciences company … Read the full press release